{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T02:49:50Z","timestamp":1779331790479,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009238","name":"Virginia Commonwealth University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.antiviral.2020.104957","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T06:54:02Z","timestamp":1603436042000},"page":"104957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Substitution-inert polynuclear platinum compounds inhibit human cytomegalovirus attachment and entry"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4821-0907","authenticated-orcid":false,"given":"Mary","family":"Shoup","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amine","family":"Ourahmane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric P.","family":"Ginsburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas P.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7949-7870","authenticated-orcid":false,"given":"Michael A.","family":"McVoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104957_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/421999","article-title":"Vaccine development to prevent cytomegalovirus disease: report from the national vaccine advisory committee","volume":"39","author":"Arvin","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.antiviral.2020.104957_bib2","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/AAC.32.11.1742","article-title":"Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus","volume":"32","author":"Baba","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104957_bib3","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1021\/mp2000583","article-title":"Effects of noncovalent platinum drug-protein interactions on drug efficacy: use of fluorescent conjugates as probes for drug metabolism","volume":"8","author":"Benedetti","year":"2011","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104957_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.antiviral.2013.07.016","article-title":"Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir","volume":"100","author":"Bhave","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104957_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1399-0012.2007.00750.x","article-title":"CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis","volume":"22","author":"Bonaros","year":"2008","journal-title":"Clin. Transplant."},{"issue":"10","key":"10.1016\/j.antiviral.2020.104957_bib6","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1128\/AAC.00854-13","article-title":"A peptide inhibitor of cytomegalovirus infection from human hemofiltrate","volume":"57","author":"Borst","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.antiviral.2020.104957_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v11070596","article-title":"Heparan sulfate proteoglycans and viral attachment: true receptors or adaptation bias?","volume":"11","author":"Cagno","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104957_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev. Med. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104957_bib9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1006\/viro.1993.1192","article-title":"Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate","volume":"193","author":"Compton","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104957_bib10","first-page":"428498","article-title":"Bacterial artificial chromosome clones of viruses comprising the Towne cytomegalovirus vaccine","author":"Cui","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.antiviral.2020.104957_bib11","doi-asserted-by":"crossref","DOI":"10.1039\/D0DT02478C","article-title":"What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks","author":"de Paiva","year":"2020","journal-title":"Dalton Trans."},{"key":"10.1016\/j.antiviral.2020.104957_bib12","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jcv.2009.10.007","article-title":"Congenital cytomegalovirus: public health action towards awareness, prevention, and treatment","volume":"46S","author":"Demmler-Harrison","year":"2009","journal-title":"J. Clin. Virol."},{"issue":"10","key":"10.1016\/j.antiviral.2020.104957_bib13","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1128\/AAC.03420-14","article-title":"Agmatine-containing poly(amidoamine)s as a novel class of antiviral macromolecules: structural properties and in vitro evaluation of infectivity inhibition","volume":"58","author":"Donalisio","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104957_bib14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/abbs\/gms041","article-title":"A faster immunofluorescence assay for tracking infection progress of human cytomegalovirus","volume":"44","author":"Duan","year":"2012","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.antiviral.2020.104957_bib15","doi-asserted-by":"crossref","first-page":"8773","DOI":"10.1039\/C5CS00201J","article-title":"Multi-platinum anti-cancer agents. Substitution-inert compounds for tumor selectivity and new targets","volume":"44","author":"Farrell","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.antiviral.2020.104957_bib16","series-title":"Advances in Inorganic Chemistry","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/bs.adioch.2019.10.003","article-title":"New perspectives and targets for the periodic table","volume":"75","author":"Farrell","year":"2020"},{"key":"10.1016\/j.antiviral.2020.104957_bib17","first-page":"109","article-title":"Metalloglycomics","volume":"18","author":"Farrell","year":"2018"},{"issue":"25","key":"10.1016\/j.antiviral.2020.104957_bib18","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1002\/chem.201706030","article-title":"Substitution-inert polynuclear platinum complexes as metalloshielding agents for heparan sulfate","volume":"24","author":"Gorle","year":"2018","journal-title":"Chem. Eur J."},{"issue":"26","key":"10.1016\/j.antiviral.2020.104957_bib19","doi-asserted-by":"crossref","first-page":"9598","DOI":"10.1021\/ic051390z","article-title":"Synthesis, characterization, and cytotoxicity of a novel highly charged trinuclear platinum compound. Enhancement of cellular uptake with charge","volume":"44","author":"Harris","year":"2005","journal-title":"Inorg. Chem."},{"issue":"6","key":"10.1016\/j.antiviral.2020.104957_bib20","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/jcph.1363","article-title":"Treatment and prevention of CMV disease in transplant Recipients\u00a0: current knowledge","volume":"59","author":"Hodowanec","year":"2019","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.antiviral.2020.104957_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.antiviral.2011.01.007","article-title":"High-content screening to distinguish between attachment and post-attachment steps of human cytomegalovirus entry into fibroblasts and epithelial cells","volume":"89","author":"Ibig-rehm","year":"2011","journal-title":"Antivir. Res."},{"issue":"6","key":"10.1016\/j.antiviral.2020.104957_bib22","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1021\/acs.inorgchem.7b03043","article-title":"Comparison of metal-ammine compounds binding to DNA and heparin. Glycans as ligands in bioinorganic chemistry","volume":"57","author":"Katner","year":"2018","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.antiviral.2020.104957_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev. Med. Virol."},{"issue":"50","key":"10.1016\/j.antiviral.2020.104957_bib24","doi-asserted-by":"crossref","first-page":"16092","DOI":"10.1021\/ja062851y","article-title":"A third mode of DNA binding: phosphate clamps by a polynuclear platinum complex","volume":"128","author":"Komeda","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2020.104957_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ica.2016.04.052","article-title":"The phosphate clamp as recognition motif in platinum\u2013DNA interactions","volume":"452","author":"Komeda","year":"2016","journal-title":"Inorg. Chim. Acta."},{"key":"10.1016\/j.antiviral.2020.104957_bib26","series-title":"Bioinorganic Chemistry and Applications","article-title":"Platinum(II) and palladium(II) complexes of pyridine-2-carbaldehyde thiosemicarbazone as alternative antiherpes simplex virus agents","author":"Kovala-Demertzi","year":"2007"},{"issue":"21","key":"10.1016\/j.antiviral.2020.104957_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.01336-18","article-title":"The human cytomegalovirus trimer and pentamer promote sequential steps in entry into epithelial and endothelial cells at cell surfaces and endosomes","volume":"92","author":"Liu","year":"2018","journal-title":"J. Virol."},{"issue":"31","key":"10.1016\/j.antiviral.2020.104957_bib28","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1039\/C3CC49695C","article-title":"A new approach to glycan targeting: enzyme inhibition by oligosaccharide metalloshielding","volume":"50","author":"Mangrum","year":"2014","journal-title":"Chem. Commun."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104957_bib29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \u201cSilent\u201d global burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104957_bib30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/viro.1999.9724","article-title":"Tetracycline-mediated regulation of gene expression within the human cytomegalovirus genome","volume":"258","author":"McVoy","year":"1999","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.antiviral.2020.104957_bib31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/095632020101200603","article-title":"In vitro activity of polyhydroxycarboxylates against herpesviruses and HIV","volume":"12","author":"Meerbach","year":"2001","journal-title":"Antiviral Chem. Chemother."},{"issue":"11","key":"10.1016\/j.antiviral.2020.104957_bib32","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40265-018-0943-1","article-title":"New developments in the management of cytomegalovirus infection after transplantation","volume":"78","author":"Meesing","year":"2018","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.antiviral.2020.104957_bib33","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1128\/AAC.00721-10","article-title":"Sulfated derivatives of Escherichia coli K5 capsular polysaccharide are potent inhibitors of human cytomegalovirus","volume":"54","author":"Mercorelli","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104957_bib34","series-title":"Biomedical Inorganic Polymers","author":"Muller","year":"2013"},{"key":"10.1016\/j.antiviral.2020.104957_bib35","first-page":"23","article-title":"Prevention of maternal cytomegalovirus infection: current status and future prospects","volume":"2","author":"Nyholm","year":"2010","journal-title":"Int. J. Wom. Health"},{"issue":"4","key":"10.1016\/j.antiviral.2020.104957_bib36","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1128\/AAC.01964-13","article-title":"DSTP-27 prevents entry of human cytomegalovirus","volume":"58","author":"Paeschke","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104957_bib37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1039\/C6SC02515C","article-title":"Antiangiogenic platinum through glycan targeting","volume":"8","author":"Peterson","year":"2017","journal-title":"Chem. Sci."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104957_bib39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2011.03.176","article-title":"The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1","volume":"90","author":"Pirrone","year":"2011","journal-title":"Antivir. Res."},{"issue":"22","key":"10.1016\/j.antiviral.2020.104957_bib40","doi-asserted-by":"crossref","first-page":"13474","DOI":"10.1093\/nar\/gku1157","article-title":"The phosphate clamp: sequence selective nucleic acid binding profiles and conformational induction of endonuclease inhibition by cationic Triplatin complexes","volume":"42","author":"Prisecaru","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2020.104957_bib41","series-title":"Polyamine Drug Discovery","first-page":"191","article-title":"Solution behavior of the phosphate clamp. DNA binding by a non-covalent polynuclear platinum compound","author":"Qu","year":"2011"},{"key":"10.1016\/j.antiviral.2020.104957_bib42","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jac\/48.6.757","article-title":"Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action","volume":"48","author":"Reefschlaeger","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104957_bib43","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/JVI.80.2.710-722.2006","article-title":"Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion","volume":"80","author":"Ryckman","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104957_bib44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0042-6822(03)00166-1","article-title":"Binding of a N,N\u2032-bisheteryl derivative of dispirotripiperazine to heparan sulfate residues on the cell surface specifically prevents infection of viruses from different families","volume":"311","author":"Schmidtke","year":"2003","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.antiviral.2020.104957_bib45","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1128\/JVI.75.9.4117-4128.2001","article-title":"Herpes simplex virus type 1 entry is inhibited by the cobalt chelate complex CTC-96","volume":"75","author":"Schwartz","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104957_bib46","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/jac\/19.6.815","article-title":"The in-vitro and in-vivo efficacy of cisplatin and analogues in the treatment of herpes simplex virus-II infections","volume":"19","author":"Snyder","year":"1987","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2020.104957_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2006.03.005","article-title":"Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART)","volume":"37","author":"Steininger","year":"2006","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2020.104957_bib48","first-page":"335","article-title":"Congenital cytomegalovirus infection: new prospects for prevention and therapy","volume":"60","author":"Swanson","year":"2013","journal-title":"Pediatr. Clin."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104957_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coviro.2012.01.001","article-title":"Human cytomegalovirus entry into cells","volume":"2","author":"Vanarsdall","year":"2012","journal-title":"Current Opinion in Virology"},{"key":"10.1016\/j.antiviral.2020.104957_bib50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1155\/MBD.1996.149","article-title":"Effect of complexes of cobalt with amino acids on the replication of herpes simplex virus type 1 (HSV-1)","volume":"3","author":"Varadinova","year":"1996","journal-title":"Met. Base. Drugs"},{"issue":"20","key":"10.1016\/j.antiviral.2020.104957_bib51","doi-asserted-by":"crossref","first-page":"10960","DOI":"10.1128\/JVI.78.20.10960-10966.2004","article-title":"Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome","volume":"78","author":"Varnum","year":"2004","journal-title":"J. Virol."},{"issue":"16","key":"10.1016\/j.antiviral.2020.104957_bib52","doi-asserted-by":"crossref","first-page":"10330","DOI":"10.1128\/JVI.79.16.10330-10338.2005","article-title":"Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism","volume":"79","author":"Wang","year":"2005","journal-title":"J. Virol."},{"issue":"50","key":"10.1016\/j.antiviral.2020.104957_bib53","doi-asserted-by":"crossref","first-page":"18153","DOI":"10.1073\/pnas.0509201102","article-title":"Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism","volume":"102","author":"Wang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:32:49Z","timestamp":1759062769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220303715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":52,"alternative-id":["S0166354220303715"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104957","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substitution-inert polynuclear platinum compounds inhibit human cytomegalovirus attachment and entry","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104957"}}